Epstein Secrets

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula E

kil Beshir Ulrich L. Bettermann Erik Behermann Jeffrey L. Bewkes Donald S. Beyer Homi K. Bhabha Neera

l Meeting EFTA_R1_02010990 EFTA02686116 Martin Dahinden Weili Dai Omotayo Dairo Henk Dalen Elizabeth Daley Charles H. Dallara James Dallas Luke J. Daly Winston Damarillo Kommer Damen Brian A. Dames Dang Thanh Tam Aliko Dangote John Eric Daniels Ronald J. Daniels John Daniszewski Richard Danzig

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

Vice-President, Quality and Medtronic Inc. USA Operations John Dalli Commissioner, Health and Consumer Policy, European Commission, Brussels Luke J. Daly Founder and Chief Executive Officer Ferrate Treatment USA Technologies Winston DamanIlo Chief Executive Officer Morphlabs Inc. USA Kommer Da

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

Vice-President, Quality and Medtronic Inc. USA Operations John Dalli Commissioner, Health and Consumer Policy, European Commission, Brussels Luke J. Daly Founder and Chief Executive Officer Ferrate Treatment USA Technologies Winston DamanIlo Chief Executive Officer Morphlabs Inc. USA Kommer Da

uan Jose Daboub Herman Daems Martin Dahinden Weili Dai Omotayo Dairo Henk van Dalen Elizabeth Daley Charles H. Dallara James Dallas John Daalli Luke J. Daly Winston Damarillo Kommer Damen Brian A. Dames Dang Thanh Tam Aliko Dangote John Eric Daniels Ronald J. Daniels John Daniszewski Richard Danziger Jac

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula Esco